{"id":"W4296613368","doi":"10.1016/s2152-2650(22)01062-x","title":"Poster: IBCL-123 inMIND: A Phase 3 Study of Tafasitamab Plus Lenalidomide and Rituximab Versus Placebo Plus Lenalidomide and Rituximab for Relapsed/Refractory (R/R) Follicular Lymphoma (FL) or Marginal Zone Lymphoma (MZL)","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Lenalidomide; Rituximab; Medicine; Follicular lymphoma; Internal medicine; Lymphoma; Refractory (planetary science); Oncology; Placebo; Pathology; Multiple myeloma; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001477133,0.001859403,0.002379227,0.0004121069,0.000604771,0.001186766,0.001254559,0.001911015,0.01692508],"category_scores_gemma":[0.000981659,0.0007439995,0.002141447,0.00023571,0.000943226,0.0008712856,0.000371852,0.004925459,0.002790826],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009203881,"about_ca_system_score_gemma":0.001471006,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0014463,"about_ca_topic_score_gemma":0.003541401,"domain_scores_codex":[0.9996368,0.0001545167,0.00001917877,0.00006332812,0.00003118168,0.00009500613],"domain_scores_gemma":[0.99946,0.0001093216,0.00007725407,0.00002499291,0.00003599603,0.0002925018],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8657396,0.03066165,0.0007593906,0.000932703,0.001376428,0.0001180064,0.0001259553,0.0009338393,0.01623628,0.0003030183,0.01156674,0.07124641],"study_design_scores_gemma":[0.7779089,0.2104351,0.002988725,0.00006997097,0.0007890732,0.0001028229,0.00004224829,0.0005084934,0.002079978,0.000197074,0.004841698,0.00003588357],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9507368,0.0139523,0.001418787,0.005568247,0.002992467,0.006625047,0.005152865,0.0005749456,0.01297868],"genre_scores_gemma":[0.9495233,0.007374506,0.003610933,0.005112691,0.001507301,0.004812261,0.004461765,0.0001603896,0.02343686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01692508,"threshold_uncertainty_score":0.05662,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0491278657640899,"score_gpt":0.3488319352136375,"score_spread":0.2997040694495476,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}